MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Progressive supranuclear palsy(PSP)"

  • MDS Virtual Congress 2020

    Niemann-Pick Type C Presenting as Progressive Supranuclear Palsy

    J. Kim, G. Lee (Busan, Republic of Korea)

    Objective: We report a very old patient who presented the clinical features of progressive supranuclear palsy (PSP) including supranuclear vertical gaze palsy with prominent cerebellar…
  • MDS Virtual Congress 2020

    Progressive supranuclear palsy: Common metabolic pattern in different variants

    G. Martí-Andrés, L. Van Bommel, S. Meles, M. Riverol, R. Valentí, R.V Kogan, R.J Renken, V. Gurvits, T. Van Laar, M. Pagani, E. Prieto, M.R Luquin, K.L Leenders, J. Arbizu (Pamplona, Spain)

    Objective: To define and cross-validate the brain glucose metabolic abnormalities in patients with a diagnosis of different PSP variants. Background: It remains unclear whether the supportive…
  • MDS Virtual Congress 2020

    The severity and distribution of tau pathology distinguish corticobasal degeneration and progressive supranuclear palsy

    S. Koga, N. Ghayal, S. Roemer, D. Dickson (Jacksonville, FL, USA)

    Objective: To elucidate whether the severity and distribution of tau pathology reflect the clinical presentations in progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD). Background:…
  • MDS Virtual Congress 2020

    Gait and motion analysis in Progressive Supranuclear Palsy

    F. Ali, S. Loushin, K. Josephs, K. Kaufman, J. Whitwell (Rochester, MN, USA)

    Objective: Evaluate gait abnormalities in progressive supranuclear palsy (PSP) with three-dimensional motion analysis. Background: PSP is associated with complex, disabling gait and balance abnormalities that…
  • MDS Virtual Congress 2020

    Can we stage tau pathology in PSP?

    G. Kovacs, M. Lukic, D. Irwin, T. Arzberger, G. Respondek, E. Lee, D. Coughlin, A. Giese, M. Grossman, C. Kurz, C. McMillan, E. Gelpi, Y. Compta, J. van Swieten, C. Troakes, S. Al-Sarraj, J. Robinson, S. Roeber, S. Xie, V. Lee, J. Trojanowski, G. Höglinger (Phildelphia, PA, USA)

    Objective: To evaluate distribution pattern of tau pathology in different PSP clinical subtypes and develop a staging system. Background: Progressive supranuclear palsy (PSP) is a…
  • MDS Virtual Congress 2020

    Identification and characterization of anti-prionic compounds that disassemble Tau prions as a novel therapeutic approach for tauopathies

    D. Willbold, T. Altendorf, W. Hoyer, J. Mohrlüder (Jülich, Germany)

    Objective: Stabilization of monomeric Tau protein by transient and high-affinity binding ligands is a novel and highly innovative anti-prionic treatment strategy for tauopathies. Background: Tauopathies…
  • MDS Virtual Congress 2020

    Successful treatment of incessant purposeless groaning in Progressive Supranuclear Palsy with Pimozide

    M. Matta, A. Panwar, N. Sawal (Chandigarh, India)

    Objective: Evaluation of therapeutic options for a patient of Progressive Supranuclear Palsy (PSP) presenting with incessant purposeless groaning. Background: PSP is a neurodegenerative disorder characterized…
  • MDS Virtual Congress 2020

    Mass spectrometry-based proteomics brain analysis to distinguish between Parkinson syndromes

    A. Rajput, P. Chumala, B. Thompson, A. Rajput, G. Katselis (Saskatoon, SK, Canada)

    Objective: To address the gap existing during clinical diagnosis in differentiating among various forms of Parkinson syndrome (PS) by using mass spectrometry (MS)-based brain proteomics.…
  • MDS Virtual Congress 2020

    Progressive supra nuclear palsy phenotype with idiopathic basal ganglia calcification

    R. Ramesh, V. Paramanandham, S. Venkatasubramanian, S. Shanmugam (Chennai, India)

    Objective: To present a rare case of progressive supra-nuclear gaze palsy (PSP) in a patient with idiopathic basal ganglia calcification in a patient with idiopathic…
  • 2019 International Congress

    Dry eye in Parkinson’s disease: symptoms, consequences and treatment options

    I. Csoti, N. Koleva-Alazeh (Leun, Germany)

    Objective: Dry eye is a common side effect of PD/PSP and easily manageable, yet its occurrence and debilitating ramifications are often unrecognized. The aim of…
  • « Previous Page
  • 1
  • …
  • 16
  • 17
  • 18
  • 19
  • 20
  • …
  • 38
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley